All Stories

  1. Antiphospholipid IgG Certified Reference Material ERM®-DA477/IFCC: a tool for aPL harmonization?

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), March 2025, De Gruyter

    Claudia Grossi

  2. 2023 American College of Rheumatology/European League Against Rheumatism antiphospholipid syndrome classification criteria solid phase–based antiphospholipid antibody domain—collaborative efforts of Antiphospholipid Syndrome Alliance for Clinical Trial...

    Article • Journal of Thrombosis and Haemostasis, January 2025, Elsevier

    Claudia Grossi

  3. TO SHOw how we have been ENgaged in the APS FiELD (What we learned on APS collaborating with Professor Yehuda Shoenfeld)

    Article • Autoimmunity Reviews, September 2024, Elsevier

    Claudia Grossi

  4. Autoantibodies testing in autoimmunity: Diagnostic, prognostic and classification value

    Article • Autoimmunity Reviews, July 2023, Elsevier

    Claudia Grossi

  5. Beta 2 glycoprotein I and neutrophil extracellular traps: Potential bridge between innate and adaptive immunity in anti-phospholipid syndrome

    Article • Frontiers in Immunology, January 2023, Frontiers

    Claudia Grossi

  6. Pathogenesis of the obstetric antiphospholipid syndrome: the key role of beta 2 glycoprotein I

    Article • Exploration of Immunology, August 2022, Open Exploration Publishing

    Claudia Grossi

  7. β2 glycoprotein I participates in phagocytosis of apoptotic neurons and in vascular injury in experimental brain stroke

    Article • Journal of Cerebral Blood Flow & Metabolism, January 2021, SAGE Publications

    Claudia Grossi

  8. Complement activation and endothelial perturbation parallel COVID-19 severity and activity

    Article • Journal of Autoimmunity, January 2021, Elsevier

    Claudia Grossi

  9. Anti-Phospholipid Antibodies in COVID-19 Are Different From Those Detectable in the Anti-Phospholipid Syndrome

    Article • Frontiers in Immunology, October 2020, Frontiers

    Claudia Grossi

  10. Complement Activation and Thrombin Generation by MBL Bound to β2-Glycoprotein I

    Article • The Journal of Immunology, September 2020, Oxford University Press (OUP)

    Claudia Grossi

  11. Anti-phospholipid antibodies in COVID-19 are different from those detectable in the anti-phospholipid syndrome

    Article • June 2020, Cold Spring Harbor Laboratory Press

    Claudia Grossi

  12. Personalized medicine in rheumatoid arthritis: How immunogenicity impacts use of TNF inhibitors

    Article • Autoimmunity Reviews, May 2020, Elsevier

    Claudia Grossi

  13. New insight into antiphospholipid syndrome: antibodies to β2glycoprotein I-domain 5 fail to induce thrombi in rats

    Article • Haematologica, November 2018, Ferrata Storti Foundation (Haematologica)

    Claudia Grossi

  14. Gene expression profiling identifies distinct molecular signatures in thrombotic and obstetric antiphospholipid syndrome

    Article • Journal of Autoimmunity, September 2018, Elsevier

    Claudia Grossi

  15. Obstetric and vascular antiphospholipid syndrome: same antibodies but different diseases?

    Article • Nature Reviews Rheumatology, June 2018, Springer Science + Business Media

    Claudia Grossi

  16. Beyond thrombosis: Anti-β2GPI domain 1 antibodies identify late pregnancy morbidity in anti-phospholipid syndrome

    Article • Journal of Autoimmunity, June 2018, Elsevier

    Claudia Grossi

  17. Fetal outcome and recommendations of pregnancies in lupus nephritis in the 21st century. A prospective multicenter study

    Article • Journal of Autoimmunity, November 2016, Elsevier

    Claudia Grossi

  18. Maternal outcome in pregnant women with lupus nephritis. A prospective multicenter study

    Article • Journal of Autoimmunity, November 2016, Elsevier

    Claudia Grossi

  19. AB0131 Tissue Beta 2 glycoprotein I in Brain Ischemic Injury

    Article • Annals of the Rheumatic Diseases, June 2016, Elsevier

    Claudia Grossi

  20. Antiphospholipid antibodies detected by line immunoassay differentiate among patients with antiphospholipid syndrome, with infections and asymptomatic carriers

    Article • Arthritis Research & Therapy, May 2016, Springer Science + Business Media

    Claudia Grossi

  21. Corrigendum to “Immune parameters identify Italian centenarians with a longer five-year survival independent of their health and functional status” [Exp. Gerontol. 54C (2014) 14–20]

    Article • Experimental Gerontology, January 2016, Elsevier

    Claudia Grossi

  22. Detection of red blood cell antibodies in mitogen-stimulated cultures from patients with hereditary spherocytosis

    Article • Transfusion, August 2015, Wiley

    Claudia Grossi

  23. AB1085 Empirical Approach to Investigate Raynaud's Phenomenon: The Pearl Study

    Article • Annals of the Rheumatic Diseases, June 2015, BMJ

    Dr Roberta Gualtierotti, Claudia Grossi

  24. Clinical Characterization of Antiphospholipid Syndrome by Detection of IgG Antibodies Against β2-Glycoprotein I Domain 1 and Domain 4/5: Ratio of Anti-Domain 1 to Anti-Domain 4/5 As a Useful New Biomarker for Antiphospholipid Syndrome

    Article • Arthritis & Rheumatology, May 2015, Wiley

    Claudia Grossi

  25. β2-glycoprotein I, lipopolysaccharide and endothelial TLR4: Three players in the two hit theory for anti-phospholipid-mediated thrombosis

    Article • Journal of Autoimmunity, December 2014, Elsevier

    Claudia Grossi

  26. International standards for IgG and IgM anti-β2glycoprotein antibody measurement

    Article • Lupus, September 2014, SAGE Publications

    Claudia Grossi

  27. Toll-like receptor 4 and β2 glycoprotein I interaction on endothelial cells

    Article • Lupus, September 2014, SAGE Publications

    Claudia Grossi

  28. AB1013 Systemic Sclerosis and Myositis Extractable Nuclear Antigen (ENA) Analysis: Profile of A Cohort of Subjects with Isolated Raynaud's Phenomenon

    Article • Annals of the Rheumatic Diseases, June 2014, BMJ

    Dr Roberta Gualtierotti, Claudia Grossi

  29. Immune parameters identify Italian centenarians with a longer five-year survival independent of their health and functional status

    Article • Experimental Gerontology, June 2014, Elsevier

    Claudia Grossi

  30. A non–complement-fixing antibody to β2 glycoprotein I as a novel therapy for antiphospholipid syndrome

    Article • Blood, May 2014, American Society of Hematology

    Claudia Grossi

  31. Fibrosis biomarkers in isolated Raynaud's phenomenon: too little, too soon?

    Article • Annals of the Rheumatic Diseases, December 2013, BMJ

    Dr Roberta Gualtierotti, Claudia Grossi

  32. A5.5 Antibodies against Domain I of β2 Glycoprotein I in Antiphospholipid Antibody Syndrome

    Article • Annals of the Rheumatic Diseases, March 2013, Elsevier

    Claudia Grossi

  33. OP0060 Beta2GPI and TLR4 interaction on endothelial cells: A bridge between innate and adaptive immunity in APS

    Article • Annals of the Rheumatic Diseases, June 2012, Elsevier

    Claudia Grossi

  34. Obstetric and vascular APS: Same autoantibodies but different diseases?

    Article • Lupus, May 2012, SAGE Publications

    Claudia Grossi

  35. Anti-phospholipid induced murine fetal loss: Novel protective effect of a peptide targeting the β2 glycoprotein I phospholipid-binding site. Implications for human fetal loss

    Article • Journal of Autoimmunity, May 2012, Elsevier

    Claudia Grossi

  36. In vivo distribution of β2 glycoprotein I under various pathophysiologic conditions

    Article • Blood, October 2011, American Society of Hematology

    Claudia Grossi

  37. Patients with antiphospholipid syndrome display endothelial perturbation

    Article • Journal of Autoimmunity, March 2010, Elsevier

    Claudia Grossi

  38. Anti-β2-glycoprotein I ELISA assay: The influence of different antigen preparations

    Article • Thrombosis and Haemostasis, January 2009, Thieme Publishing Group

    Claudia Grossi

  39. Chapter 4 Mechanisms of Action of Antiphospholipid Antibodies

    Article • January 2009, Elsevier

    Claudia Grossi

  40. Toll-like receptors: another player in the pathogenesis of the anti-phospholipid syndrome

    Article • Lupus, October 2008, SAGE Publications

    Claudia Grossi

  41. Antiphospholipid Antibodies and the Antiphospholipid Syndrome: Pathogenic Mechanisms

    Article • Seminars in Thrombosis and Hemostasis, April 2008, Thieme Publishing Group

    Claudia Grossi

  42. Updating on the Pathogenic Mechanisms 5 of the Antiphospholipid Antibodies-Associated Pregnancy Loss

    Article • Clinical Reviews in Allergy & Immunology, January 2008, Springer Science + Business Media

    Claudia Grossi

  43. Role of anti-β2 glycoprotein I antibodies in antiphospholipid syndromeglycoprotein I antibodies in antiphospholipid syndrome

    Article • Clinical Reviews in Allergy & Immunology, February 2007, Springer Science + Business Media

    Claudia Grossi

  44. Decreased sialylation of the acute phase protein α1-acid glycoprotein in feline infectious peritonitis (FIP)

    Article • Veterinary Immunology and Immunopathology, June 2004, Elsevier

    Claudia Grossi